BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 72.70
arrow_upward
+1.54%(+1.10) 1D
Nov 13, 5:30:00 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHF 71.30
High
CHF 73.80
Low
CHF 71.30
Mkt. cap
977.69M
Avg. vol.
31.08K
Volume
26.18K
P/E ratio
18.98
52-wk high
CHF 75.80
52-wk low
CHF 45.85
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
Open
CHF 71.30
High
CHF 73.80
Low
CHF 71.30
Mkt. cap
977.69M
Avg. vol.
31.08K
Volume
26.18K
P/E ratio
18.98
52-wk high
CHF 75.80
52-wk low
CHF 45.85
EPS
CHF 3.83
Shares outstanding
13.45M
No. of employees
200
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Basilea Pharmaceutica (SWX:BSLN) Stock Still Looks Undervalued Despite A 101% Run
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil
CEODavid Veitch
Employees200
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebasilea.com